Archive for April, 2010

Older Entries
Newer Entries

American Heart Association: Superior Outcomes in STEMI after Low-Molecular-Weight Heparin

13, Apr 2010

Speaker: Marc S. Sabatine, MD, Associate Physician, Cardiovascular Division, Brigham & Women’s Hospital, and Instructor in Medicine, Harvard Medical School, Boston, Massachusetts The use of a low-molecular-weight heparin (LMWH) plus other standard therapies, including aspirin and clopidogrel (Plavix) may be associated with improved angiographic outcomes, lower rates of major adverse cardiovascular events, and an absence [...]

American Heart Association: Omega-3 Fatty Acid Supplementation Improves Lipid Profile in Overweight Children

12, Apr 2010

Speaker: Gary A. Mayman, MD, Associate Professor, Cardiology Section, Department of Pediatrics, University of Nevada School of Medicine, and Co-Director, Children’s Heart Center, Las Vegas, Nevada A group of overweight children who received a dietary supplement of fish oil containing omega-3 fatty acids (Omega RX, Zone Labs), showed a significant improvement in their lipid profiles, [...]

American Heart Association

11, Apr 2010

Extended-Release Niacin for Dyslipidemic Patients with HIV Infection Speaker: James H. Stein, MD, Associate Professor, Section of Cardiovascular Medicine, Department of Medicine, University of Wisconsin Medical School, Madison, Wisconsin Extended-release (ER) niacin (Niaspan, Kos), well known for its value in lowering low-density lipoprotein-cholesterol (LDL-C) and total cholesterol and its ability to increase HDL-cholesterol (HDL-C) in [...]

American Academy of Pain Medicine: Transdermal Hydromorphone Patch for Acute Postoperative Pain

8, Apr 2010

Speaker: Edda Gomez-Panzani, MD, Director of Clinical Research and Development, and Head of Medical Affairs, Altea Therapeutics, Tucker, Georgia An investigational transdermal hydromorphone patch (Altea Therapeutics) seems to be effective for patients with moderate-to-severe acute pain after knee or hip replacement surgery. The delivery of hydromorphone through the skin was achieved by Altea’s patented PassPort [...]

American Academy of Pain Medicine: Adjunctive Intrathecal Ziconotide: An Alternative Approach to Chronic Pain

7, Apr 2010

Adjunctive Intrathecal Ziconotide: An Alternative Approach to Chronic Pain Speaker: Alexander A. Krakovsky, MD, PhD, DrSc, Pain Management Specialist, Interventional Pain Management, Galileo Medical Center, San Luis Obispo, California Adjunctive intrathecal therapy with ziconotide (Prialt, Elan) represents the first of a new class of non-opioid analgesics called N-type calcium-channel blockers. This novel approach is used [...]

American Academy of Pain Medicine

6, Apr 2010

Once-Daily Extended-Release Morphine Sulfate Beneficial for Low Back Pain Speaker: Richard L. Rauck, MD, Medical Director, The Center for Clinical Research, LLC; Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina Once-daily extended-release (ER) morphine sulfate (Avinza, Ligand) proved superior to twice-a-day, controlled-release oxycodone HCl (OxyContin, Purdue Pharma) for chronic, moderate-to-severe low back pain in [...]

Digestive Disease Week: part 2

2, Apr 2010

Ulcerative Colitis The Mesalamine Study A formulation of mesalamine generic designed to provide both sustained and late release in the colon may increase compliance and thus promote better outcomes compared with existing 5-aminosalicylic acid (5-ASA) therapies. William J. Sandborn, MD, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, noted that existing 5-ASA formulations [...]

Pages: Prev 1 2 3 4 Next

Older Entries
Newer Entries
top